| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epidemiology and Outcomes |

,

,

* Department of Medicine, Division of Nephrology, and || Department of Medical Biochemistry, St. Olav University Hospital, and
Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway;
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, and
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; ¶ Department of Medicine, Levanger Hospital, Levanger, Norway; and ** HUNT Research Centre, Faculty of Medicine, Norwegian University of Science and Technology, Verdal, Norway
Address correspondence to: Dr. Stein I. Hallan, Department of Medicine, Division of Nephrology, St. Olav University Hospital, N-7006 Trondheim, Norway. Phone: +47-73867472; Fax: +47-73869390; stein.hallan{at}ntnu.no
Received for publication December 9, 2005. Accepted for publication May 5, 2006.
ESRD incidence is much lower in Europe compared with the United States. This study investigated whether this reflects a difference in the prevalence of earlier stages of chronic kidney disease (CKD) or other mechanisms. CKD prevalence in Norway was estimated from the population-based Health Survey of Nord-Trondelag County (HUNT II), which included 65,181 adults in 1995 through 1997 (participation rate 70.4%). Data were analyzed using the same methods as two US National Health and Nutrition Examination Surveys in 1988 through 1994 (n = 15,488) and 1999 through 2000 (n = 4101). The primary analysis used gender-specific cutoffs in estimating persistent albuminuria for CKD stages 1 and 2. ESRD rates and other relevant data were extracted from national registries. Total CKD prevalence in Norway was 10.2% (SE 0.5): CKD stage 1 (GFR >90 ml/min per 1.73 m2 and albuminuria), 2.7% (SE 0.3); stage 2 (GFR 60 to 89 ml/min per 1.73 m2 and albuminuria), 3.2% (SE 0.4); stage 3 (GFR 30 to 59 ml/min per 1.73 m2), 4.2% (SE 0.1); and stage 4 (GFR 15 to 29 ml/min per 1.73 m2), 0.2% (SE 0.01). This closely approximates reported US CKD prevalence (11.0% in 1988 through 1994 and 11.7% in 1999 through 2000). The relative risk for progression from CKD stages 3 or 4 to ESRD in US white patients compared with Norwegian patients was 2.5. This was only modestly modified by adjustment for age, gender, and diabetes. Age and GFR at start of dialysis were similar, hypertension and cardiovascular mortality in the populations were comparable, but US white patients were referred later to a nephrologist and had higher prevalence of obesity and diabetes. In conclusion, CKD prevalence in Norway was similar to that in the United States, suggesting that lower progression to ESRD rather than a smaller pool of individuals at risk accounts for the lower incidence of ESRD in Norway.
Related Articles
J. Am. Soc. Nephrol. 2006 17: 2092-2093.
J. Am. Soc. Nephrol. 2006 17: 2094-2096.
This article has been cited by other articles:
![]() |
E. K. Sumaili, J.-M. Krzesinski, C. V. Zinga, E. P. Cohen, P. Delanaye, S. M. Munyanga, and N. M. Nseka Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo Nephrol. Dial. Transplant., January 1, 2009; 24(1): 117 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Moranne, M. Froissart, J. Rossert, C. Gauci, J.-J. Boffa, J. P. Haymann, M. B. M'rad, C. Jacquot, P. Houillier, B. Stengel, et al. Timing of Onset of CKD-Related Metabolic Complications J. Am. Soc. Nephrol., January 1, 2009; 20(1): 164 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ishani, J. L. Xue, J. Himmelfarb, P. W. Eggers, P. L. Kimmel, B. A. Molitoris, and A. J. Collins Acute Kidney Injury Increases Risk of ESRD among Elderly J. Am. Soc. Nephrol., January 1, 2009; 20(1): 223 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Gansevoort and E. Ritz Hermann Senator and albuminuria--forgotten pioneering work in the 19th century Nephrol. Dial. Transplant., December 10, 2008; (2008) gfn741v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, W. Chen, H. Wang, X. Dong, Q. Liu, H. Mao, J. Tan, J. Lin, F. Zhou, N. Luo, et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China Nephrol. Dial. Transplant., October 24, 2008; (2008) gfn604v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Hwang, M.-Y. Lin, H.-C. Chen, S.-C. Hwang, W.-C. Yang, C.-C. Hsu, H.-C. Chiu, and L.-W. Mau Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3192 - 3198. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. de Jong and R. T. Gansevoort Fact or fiction of the epidemic of chronic kidney disease--let us not squabble about estimated GFR only, but also focus on albuminuria Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1092 - 1095. [Full Text] [PDF] |
||||
![]() |
R. J. Glassock and C. Winearls An epidemic of chronic kidney disease: fact or fiction? Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1117 - 1121. [Full Text] [PDF] |
||||
![]() |
P. E. de Jong, M. van der Velde, R. T. Gansevoort, and C. Zoccali Screening for Chronic Kidney Disease: Where Does Europe Go? Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 616 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Calderon-Margalit, E.-S. Gordon, M. Hoshen, J. D. Kark, A. Rotem, and Z. Haklai Dialysis in Israel, 1989-2005--time trends and international comparisons Nephrol. Dial. Transplant., February 1, 2008; 23(2): 659 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bassilios, P. Martel, V. Godard, M. Froissart, J.-P. Grunfeld, B. Stengel, and on behalf of the Reseau Nephropar Monitoring of glomerular filtration rate in lithium-treated outpatients--an ambulatory laboratory database surveillance Nephrol. Dial. Transplant., February 1, 2008; 23(2): 562 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.M.P. Annear, D. Banerjee, J. Joseph, T.H. Harries, S. Rahman, and J.B. Eastwood Prevalence of chronic kidney disease stages 3-5 among acute medical admissions: another opportunity for screening QJM, February 1, 2008; 101(2): 91 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Orth and S. I. Hallan Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients Absence of Evidence or Evidence of Absence? Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 226 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hallan, B. Astor, S. Romundstad, K. Aasarod, K. Kvenild, and J. Coresh Association of Kidney Function and Albuminuria With Cardiovascular Mortality in Older vs Younger Individuals: The HUNT II Study Arch Intern Med, December 10, 2007; 167(22): 2490 - 2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. MacGregor How common is early chronic kidney disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix8 - ix18. [Full Text] [PDF] |
||||
![]() |
F. Caskey, R. Steenkamp, and D. Ansell International comparison of UK registry data (Chapter 17) Nephrol. Dial. Transplant., August 1, 2007; 22(suppl_7): vii185 - vii193. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. DuBose Jr. American Society of Nephrology Presidential Address 2006: Chronic Kidney Disease as a Public Health Threat--New Strategy for a Growing Problem J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1038 - 1045. [Full Text] [PDF] |
||||
![]() |
W. G. Couser, S. Shah, and For the joint international Society of Nephrology/ A call to action on World Kidney Day, 8 March 2007 Nephrol. Dial. Transplant., March 1, 2007; 22(3): 676 - 677. [Full Text] [PDF] |
||||
![]() |
K. J. Jager and P. C. W. van Dijk Has the rise in the incidence of renal replacement therapy in developed countries come to an end? Nephrol. Dial. Transplant., March 1, 2007; 22(3): 678 - 680. [Full Text] [PDF] |
||||
![]() |
C.-y. Hsu, A. S. Go, C. E. McCulloch, J. Darbinian, and C. Iribarren Exploring Secular Trends in the Likelihood of Receiving Treatment for End-Stage Renal Disease Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 81 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ruggenenti and G. Remuzzi Kidney Failure Stabilizes after a Two-Decade Increase: Impact on Global (Renal and Cardiovascular) Health Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 146 - 150. [Full Text] [PDF] |
||||
![]() |
H. Wasse and W. McClellan Risk for Progression to ESRD: Further Evidence from Population-Based Studies J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2092 - 2093. [Full Text] [PDF] |
||||
![]() |
B. Stengel and C. Couchoud Chronic Kidney Disease Prevalence and Treated End-Stage Renal Disease Incidence: A Complex Relationship J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2094 - 2096. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673